Navigation Links
Zeus Webinar: Bioabsorbable Polymers as Biomaterials
Date:8/22/2008

Anticipated to promote greater awareness and understanding in the field of bioabsorbable polymers, Zeus presents free webinar on August 28, 2008

ORANGEBURG, S.C., Aug. 22 /PRNewswire/ -- Zeus, Inc., a leader in polymer science, is pleased to announce it will be hosting an informative and cutting-edge bioabsorbables webinar entitled, "Bioabsorbable Polymers as Biomaterials." Presented by Dr. Bruce Anneaux and James Lindsey, the webinar will provide insight into the development of synthetic bioabsorbable and biodegradable polymers and the application of these materials in the medical device industry. To register or for more details about this free webinar and its presenters, visit "New Information" at http://www.zeusinc.com.

Commenting on the webinar, Dr. Bruce Anneaux, Corporate Manager, Research & Development, said, "Zeus is committed to exploring and advancing innovative concepts and the widespread application of bioabsorbable polymers into the medical industry has the potential to revolutionize this field. It is this potential that makes this webinar particularly relevant and significant."

The webinar will focus primarily on the commercially available synthetic bioabsorbable polyesters with an emphasis on copolymer design. Attendees will also gain valuable information related to the following sub-topics:

-- Bioabsorbable Polymer Applications

-- Bioabsorbable Polyester Design

-- Biodegradation

-- Processing

-- Sterilization

-- Packaging

"There has been steady growth in the area of biomaterials and this webinar will provide insight into many of these advances as it relates to the medical device industry," said James Lindsey, Research Engineer. "The webinar seeks to enhance participants' understanding of the science of bioabsorbable materials and promote greater awareness of the many possibilities that lie ahead."

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC, USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications, operating 10 facilities on seven campuses in North America, Europe, and Asia. Zeus products and services are preferred by companies in medial, automotive, electrical fluid handling and mechanical markets. For more information, visit http://www.zeusinc.com.

Contact:

Creative Media Group

Email: publicrelations@zeusinc.com

866.272.4710

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Zeus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
2. Researchers engineer new polymers to change their stiffness and strength when exposed to liquids
3. Copolymers block out new approaches to microelectronics at NIST
4. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
5. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
6. ULURU Inc. to Present at the 8th World Biomaterials Congress
7. Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... PHILADELPHIA , Feb. 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immune system to find a better treatment for triple negative ... Start in France program. ... is an accelerator designed to help entrepreneurs grow their business ... was one of eight American companies selected to complete an ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):